- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ArmaGen, Inc
Total 36849 results
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction CancerKorea, Republic of, Taiwan, Japan, Singapore, United States
-
AmgenRecruitingActive Juvenile Psoriatic ArthritisSpain, United Kingdom, Turkey, Belgium, France, Greece, Italy, Austria, Germany, Netherlands, Poland, Portugal, Romania, Lithuania, South Africa
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AmgenWithdrawn
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
AmgenTerminatedLupus NephritisSpain, Brazil, Taiwan, Thailand, Croatia, Serbia, United States, Malaysia, Poland, Philippines, Argentina, Israel
-
AmgenCompletedGout | Chronic Uncontrolled Gout | Uncontrolled GoutUnited States
-
AmgenTerminatedSystemic Lupus ErythematosusUnited States, Spain, Serbia, Mexico, Poland, Greece, Argentina, India, Taiwan
-
AmgenCompletedMigraine HeadacheUnited States, Austria, Australia, Czechia, Finland, France, Hungary, Italy, Poland, Portugal, Spain, United Kingdom
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
AmgenCompletedSystemic Lupus ErythematosusUnited States
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
AmgenActive, not recruitingRelapsed/Refractory Small Cell Lung CancerUnited States, Belgium, Italy, Spain, Portugal, Austria, Greece, Korea, Republic of, Denmark, Netherlands, Germany, France, Taiwan, Japan, United Kingdom, Poland, Switzerland, Singapore
-
AmgenCompletedSystemic Lupus Erythematosus (SLE)United States, Korea, Republic of, Australia, Spain, Hungary, Bulgaria, Italy, Mexico, Germany, Japan, France, Greece, Czechia, Argentina, Portugal, Poland, Russian Federation, Hong Kong, Canada
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
AmgenCompletedAdvanced Non CNS TumorsUnited States, Belgium, Spain, France, Canada, Italy, Switzerland
-
AmgenCompletedPlaque PsoriasisUnited States, Poland, Canada, Germany, Estonia, Latvia
-
AmgenActive, not recruitingPalmoplantar PustulosisJapan
-
AmgenTerminatedGastric and Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
-
AmgenCompleted
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
AmgenCompletedPsoriasisUnited States, Poland, Canada, Germany, Estonia, Georgia, Hungary, Latvia
-
AmgenCompleted
-
AmgenCompletedChronic Myelomonocytic Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
AmgenCompletedGiant Cell Tumor of BoneAustralia, France, United States, Spain, Italy, Poland, Sweden, United Kingdom
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
AmgenCompletedArthritis, PsoriaticNetherlands
-
AmgenWithdrawn
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedElectrocardiographyUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France
-
AmgenCompletedGastric or Gastroesophageal CancerJapan
-
AmgenCompletedDyslipidemia | Medical Conditions to be Studied | ASCVD ManagementUnited States
-
AmgenTerminatedMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
AmgenCompletedPsoriatic ArthritisSpain, Belgium, Denmark, United States, Germany, Russian Federation, Austria, United Kingdom, Canada, Italy, Switzerland
-
AmgenTerminatedDyslipidemiaBelgium, Denmark, Germany, Sweden, France, Italy, Portugal
-
AmgenCompletedHealthy VolunteersUnited States
-
AmgenCompleted
-
AmgenCompletedRheumatoid ArthritisUnited States, Germany, Italy, Mexico, France, Canada, Hungary, Portugal, Spain, Greece, Bulgaria, Czechia, Poland, Argentina, South Africa